PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System, a patient-centric solution for urge urinary ...

PARK CITY, Utah, Nov. 6, 2023 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for ...

A new wave of innovation may reshape how clinicians approach some of the most persistent challenges in patient care. Non-invasive neuromodulation, a technique that uses gentle electrical stimulation ...

Axonics (NASDAQ:AXNX) said it acquired a lead placement solution from Radian which complements the company's existing sacral neuromodulation (SNM) offering. The company acquired the assets of Radian ...

Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by recurrent reflux of stomach contents into the esophagus, leading to troublesome symptoms such as heartburn, ...

CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and ...

The growth of the neuromodulation market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on ...

We expect free cash flow to improve through the year as the pandemic-driven delays in neuromodulation procedures ease. Cash flow growth should accelerate as we head into 2023. The firm does not pay a ...

LivaNova delivered strong third-quarter results that slightly outpaced our expectations, however, our adjustments for the near term weren’t material enough to shift our fair value estimate. Our more ...